The research and development team at Next Pharmaceuticals follows a specific protocol when investigating a novel raw material or developing a new proprietary blend. First and foremost, a new offering must fit into a product category for which innovative ingredients are lacking. From there, the exploration begins with an extensive worldwide literature search.
The team is looking for the chemical compounds, active ingredients and methods for preparation of each material. In addition, pharmacological activity, bioavailability and toxicology are assessed. The final step in the literature search is to evaluate published in vitro, animal and human trials.
Once a raw material has been deemed suitable, the team examines its commercial viability to ensure that the material is plentiful and that potential harvesting will not damage the environment. At this stage, an appropriate manufacturer is sourced and the material is produced in a quantity that can satisfy industry needs. Lastly, Next Pharmaceuticals begins its own trials starting with acute toxicology and moving on to human trials. This protocol can take years to complete. It is the sole purpose of Next Pharmaceuticals to offer safe and efficacious raw materials.